CAMBRIDGE, Mass.--(BUSINESS WIRE)--Altus Pharmaceuticals Inc. (NASDAQ: ALTU), a biopharmaceutical company focused on oral and injectable protein therapeutics for patients with gastrointestinal and metabolic disorders, is scheduled to participate in the Lazard Capital Markets Fourth Annual Healthcare Conference at The Palace Hotel in New York, New York on Wednesday, November 28, 2007.
